(Q54565254)

1 June 2018

title

Effects of DPP-4 inhibition on cardiac metabolism and function in mice. (English)

1 reference

1 June 2018

author name string

M Lenski

1

1 reference

1 June 2018

A Kazakov

2

1 reference

1 June 2018

N Marx

3

1 reference

1 June 2018

M Böhm

4

1 reference

1 June 2018

U Laufs

5

1 reference

1 June 2018

publication date

12 August 2011

1 reference

1 June 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

1 June 2018

volume

51

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

906-918

1 reference

1 June 2018

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Utilization of energy-providing substrates in the isolated working rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Contraction-Induced Fatty Acid Translocase/CD36 Translocation in Rat Cardiac Myocytes Is Mediated Through AMP-Activated Protein Kinase Signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Expression of dipeptidyl peptidase IV in rat tissues is mainly regulated at the mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Role of CD26/dipeptidyl peptidase IV in human T cell activation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Targets for intervention in dyslipidemia in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Cardiac fatty acid uptake and transport in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Lipotoxic heart disease in obese rats: implications for human obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Kinetics of the creatine kinase reaction in neonatal rabbit heart: an empirical analysis of the rate equation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

TSC2 mediates cellular energy response to control cell growth and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

TOR, a central controller of cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

The role of AGEs in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth fac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Induction of cardiac fibrosis by transforming growth factor-beta(1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Norepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.001

10.1016/J.YJMCC.2011.08.001

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018